When a research chemist or procurement manager searches for a ‘research-grade chemical supplier,’ they are looking for a specific quality standard — high purity, reliable documentation, and lot-to-lot consistency that their experiments depend on. What they often encounter instead is a supplier who uses ‘research grade’ as a marketing phrase without the analytical data to […]
Drug discovery is a chemistry problem before it is a biology problem, a clinical problem, or a regulatory problem. The compounds that go into an early-stage drug discovery program — the building blocks assembled into candidate structures, the intermediates produced along the synthesis route, the reference standards used to validate analytical methods — determine what […]
Building and maintaining in-house synthetic chemistry capacity is expensive. A fully equipped synthetic chemistry lab — personnel, equipment, reagents, safety infrastructure, QC capability — represents a significant fixed cost that only makes economic sense when it is operating at high utilization across a continuous pipeline of synthesis needs. For many pharmaceutical companies, biotech startups, materials […]
